Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic Syndrome

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(18 sites)

Japan

Anjo Kosei Hospital, Anjo, Aichi-ken

Kasugai Municipal Hospital, Kasugai, Aichi-ken

Konan Kosei Hospital, Kōnan, Aichi-ken

Nagoya University Hospital, Nagoya, Aichi-ken

Fujita Health University hospital, Toyoake, Aichi-ken

Juntendo University Urayasu Hospital, Urayasu, Chiba

Kyushu University Hospital, Fukuoka, Fukuoka

Kurume University Hospial, Kurume, Fukuoka

Asahikawa Medical University Hospital, Asahikawa, Hokkaido

Kanazawa University Hospital, Kanazawa, Ishikawa-ken

Kumamoto University Hospital, Kumamoto, Kumamoto

University Hospital,Kyoto Prefectural University of Medicine, Kyoto, Kyoto

Kyoto University Hospital, Kyoto, Kyoto

Mie University Hospial, Tsu, Mie-ken

Tohoku University Hospital, Sendai, Miyagi

Tazuke Kofukai, Medical Research Institute, Kitano Hospital, Osaka, Osaka

Osaka University Hospital, Osaka, Osaka

Hamamatsu University Hosptial, Hamamatsu, Shizuoka